James Edgemond - Net Worth and Insider Trading

James Edgemond Net Worth

The estimated net worth of James Edgemond is at least $3 Million dollars as of 2024-11-05. James Edgemond is the CFO AND TREASURER of United Therapeutics Corp and owns about 7,512 shares of United Therapeutics Corp (UTHR) stock worth over $3 Million. Details can be seen in James Edgemond's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Edgemond has not made any transactions after 2024-10-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of James Edgemond

To

James Edgemond Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Edgemond owns 1 companies in total, including United Therapeutics Corp (UTHR) .

Click here to see the complete history of James Edgemond’s form 4 insider trades.

Insider Ownership Summary of James Edgemond

Ticker Comapny Transaction Date Type of Owner
UTHR United Therapeutics Corp 2024-10-28 CFO and Treasurer

James Edgemond Latest Holdings Summary

James Edgemond currently owns a total of 1 stock. James Edgemond owns 7,512 shares of United Therapeutics Corp (UTHR) as of October 28, 2024, with a value of $3 Million.

Latest Holdings of James Edgemond

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
UTHR United Therapeutics Corp 2024-10-28 7,512 381.85 2,868,457

Holding Weightings of James Edgemond


James Edgemond Form 4 Trading Tracker

According to the SEC Form 4 filings, James Edgemond has made a total of 12 transactions in United Therapeutics Corp (UTHR) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in United Therapeutics Corp is the sale of 7,800 shares on October 28, 2024, which brought James Edgemond around $3 Million.

Insider Trading History of James Edgemond

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James Edgemond Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James Edgemond Ownership Network

Ownership Network List of James Edgemond

No Data

Ownership Network Relation of James Edgemond

Insider Network Chart

James Edgemond Owned Company Details

What does United Therapeutics Corp do?

Who are the key executives at United Therapeutics Corp?

James Edgemond is the CFO and Treasurer of United Therapeutics Corp. Other key executives at United Therapeutics Corp include President and COO Michael Benkowitz , director & Chief Executive Officer Martine A Rothblatt , and EVP & General Counsel Paul A Mahon .

United Therapeutics Corp (UTHR) Insider Trades Summary

Over the past 18 months, James Edgemond made 12 insider transaction in United Therapeutics Corp (UTHR) with a net sale of 125,940. Other recent insider transactions involving United Therapeutics Corp (UTHR) include a net sale of 707,954 shares made by Martine A Rothblatt , a net sale of 128,500 shares made by Paul A Mahon , and a net sale of 14,360 shares made by Christopher Causey .

In summary, during the past 3 months, insiders sold 186,469 shares of United Therapeutics Corp (UTHR) in total and bought 0 shares, with a net sale of 186,469 shares. During the past 18 months, 1,062,383 shares of United Therapeutics Corp (UTHR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,062,383 shares.

United Therapeutics Corp (UTHR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

United Therapeutics Corp Insider Transactions

No Available Data

James Edgemond Mailing Address

Above is the net worth, insider trading, and ownership report for James Edgemond. You might contact James Edgemond via mailing address: 1040 Spring Street, Silver Spring Md 20910.